Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New dual allosteric Akt inhibitors show promise in cancer models

May 14, 2012

Potent novel ALK inhibitors presented

May 14, 2012

Novel VEGF-A-binding antibody for age-related macular degeneration presented

May 11, 2012

New clinical data reported on drug for generalized anxiety disorder and depression

May 11, 2012

Collaborating European universities identify new candidate biomarker of Sjogren's syndrome

May 11, 2012

Researchers detail effects of lisdexamfetamine in patients with depression/chronic fatigue syndrome

May 11, 2012

Translation inhibitors show potential in breast cancer models

May 11, 2012

Seattle Genetics molecule inhibits fucosylation in vitro and in vivo

May 10, 2012

Further phase III data reported on SNRI for depression

May 10, 2012

New Kyowa Hakko Kirin product demonstrates anticancer activity

May 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...